AAV Production Starts with the Right Materials: How Seamless Bio Supports Every Stage of Your Workflow
Adeno-associated virus (AAV) vectors are critical to gene therapy. Their use in delivering genetic material into target cells has transformed modern medicine, from rare disease treatment to oncology and vaccine development. But producing AAVs isn't simple. It requires precise upstream and downstream processes — and most importantly, reliable biological raw materials.